Healthcare News and Research

Latest Healthcare News and Research

Mice study shows specific energy source responsible for performing complex cognitive functions

New research suggests that certain types of brain cells may be "picky eaters," seeming to prefer one specific energy source over others.

9 May 2014

Genzyme, Isis receive 2014 Partners in Progress Corporate Award for KYNAMRO injection

Genzyme, a Sanofi company, and Isis Pharmaceuticals Inc., today announced that they have received the 2014 Partners in Progress Corporate Award from NORD in recognition of KYNAMRO (mipomersen sodium) injection.

9 May 2014

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

Teva Pharmaceutical Industries Ltd., today announced that COPAXONE (glatiramer acetate injection), the #1 global therapy for relapsing multiple sclerosis, has been named the 2014 "Brand of The Year" by Pharmaceutical Executive Magazine, a leading print and online publication for the biopharmaceutical industry.

9 May 2014

HHS finds hospitals getting safer

The administration credited the improvements at least partially to the Affordable Care Act.

9 May 2014

ApolloMed's revenues grow 35% to $10.5 million in fiscal 2014

Apollo Medical Holdings, Inc., an integrated, physician-centric healthcare delivery company, today announced financial results for the 12 months ended January 31, 2014.

9 May 2014

ImaginAb announces completion of $21M Series B financing

ImaginAb, Inc., a clinical stage biotechnology company that engineers antibodies into smaller protein formats optimized for in vivo molecular imaging, announced today the completion of a $21M Series B financing of the company, led by Mérieux Développement and syndicated with Novartis Venture Funds, Cycad Group and Nextech Invest.

9 May 2014

Freeman Health System wins 2014 Truven Health Advantage Award for Overall Performance

Mike Boswood, president and CEO of Truven Health Analytics presented the 2014 Truven Health Advantage Award for Overall Performance to Freeman Health System, a not-for-profit, three-hospital system in Joplin, Missouri.

8 May 2014

NxStage Medical reports revenue of $72.2 million for first quarter 2014

NxStage Medical, Inc., a leading manufacturer of innovative dialysis products, today reported record first quarter financial results that exceed the top end of its guidance range.

8 May 2014

Adults with learning disabilities hear better through new support service in Sheffield

MORE adults with learning disabilities and impaired hearing are using their hearing aids correctly thanks to a new technical support service provided by Sheffield Teaching Hospitals NHS Foundation Trust.

8 May 2014

Finding has implications for understanding cognitive decline in degenerative diseases

New research suggests that certain types of brain cells may be "picky eaters," seeming to prefer one specific energy source over others. The finding has implications for understanding the cognitive decline seen in aging and degenerative diseases such as Alzheimer's and multiple sclerosis.

8 May 2014

First Edition: May 8, 2014

Today's headlines include reports from a Capitol Hill hearing featuring health insurers' testimony about their experiences with new enrollment under the health law.

8 May 2014

Consumer Reports finds that only some hospitals help mothers avoid unnecessary C-sections

A Consumer Reports analysis of over 1,500 hospitals in 22 U.S. states suggests that some hospitals do a much better job than others at helping mothers avoid unnecessary C-sections.

8 May 2014

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland

The International Partnership for Microbicides announced today that it has received exclusive worldwide rights to a promising HIV prevention medicine called dapivirine from Janssen R&D Ireland, one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

8 May 2014

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen Research & Development, LLC (Janssen) today announced it has submitted a Supplemental New Drug Application (sNDA) to the U.S. Food and Drug Administration (FDA) for simeprevir, an NS3/4A protease inhibitor marketed as OLYSIO™ in the United States, in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.

8 May 2014

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Janssen R&D Ireland Ltd. (Janssen) today announced that it has expanded its collaboration with the International Partnership for Microbicides (IPM) for the development and delivery of dapivirine (TMC120) for the prevention of HIV.

8 May 2014

Researchers to develop unique technology to help physicians perform ultrasound-guided procedures involving needle placement

Significant funding from NIBIB has enabled researchers to develop a unique technology to help physicians perform ultrasound-guided procedures involving needle placement such as needle biopsies, central line insertion, and local anesthesia.

8 May 2014

State highlights: SEIU, hospital strike deal in Calif.; N.Y. Medicaid audit; dental therapists

A selection of health policy stories from California, New York, Connecticut, Georgia, Indiana and North Carolina.

8 May 2014

Children who spend more hours in front of screen have high blood pressure

A new study reveals that children who spend two hours or more in front of a screen (TV, computer, videogames etc.) have over 2.5 fold increase in their odds of having high blood pressure (BP). These odds are increased further by overweight and obesity.

8 May 2014

Viewpoints: Evidence for Obamacare saving lives; a continuing role for Minnesotacare

People asking the ultimate question about the Affordable Care Act--will it actually save lives?--now have an answer, and it's yes.

8 May 2014

Research may have "major implications" for treatment of urinary tract infections in children

A major new pediatric research study led by a Wayne State University researcher, funded by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (NIH) and published this week in the New England Journal of Medicine (NEJM), has "major implications" for the treatment of urinary tract infections (UTIs) in millions of American children.

8 May 2014

Healthcare News and Research

Latest Healthcare News and Research

Mice study shows specific energy source responsible for performing complex cognitive functions

Genzyme, Isis receive 2014 Partners in Progress Corporate Award for KYNAMRO injection

Pharmaceutical Executive Magazine names COPAXONE therapy as 2014 "Brand of The Year"

HHS finds hospitals getting safer

ApolloMed's revenues grow 35% to $10.5 million in fiscal 2014

ImaginAb announces completion of $21M Series B financing

Freeman Health System wins 2014 Truven Health Advantage Award for Overall Performance

NxStage Medical reports revenue of $72.2 million for first quarter 2014

Adults with learning disabilities hear better through new support service in Sheffield

Finding has implications for understanding cognitive decline in degenerative diseases

First Edition: May 8, 2014

Consumer Reports finds that only some hospitals help mothers avoid unnecessary C-sections

IPM gains exclusive worldwide rights to promising HIV prevention medicine from Janssen R&D Ireland

Janssen submits sNDA to FDA for simeprevir in combination with sofosbuvir for treatment of HCV genotype 1 infection

Janssen expands collaboration with IPM for development of dapivirine to prevent HIV

Researchers to develop unique technology to help physicians perform ultrasound-guided procedures involving needle placement

State highlights: SEIU, hospital strike deal in Calif.; N.Y. Medicaid audit; dental therapists

Children who spend more hours in front of screen have high blood pressure

Viewpoints: Evidence for Obamacare saving lives; a continuing role for Minnesotacare

Research may have "major implications" for treatment of urinary tract infections in children

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Healthcare News and Research

Latest Healthcare News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in